Drug

Cefotetan clinical trials

studies test it: 4
open now: 1
in phase 3: 1
first study started: 2002

How each study uses Cefotetan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Cefotetan studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Approvals

The first approval found in each region, with its record

United States: 27 Dec 1985 · CEFOTAN · NDA 050588 (FDA, Drugs@FDA)
European Union: Not in EMA's list of EU-wide authorisations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Cefotetan: 3

Studies by the year they started

4 studies that test it; most in 2002 (1)

Studies that test Cefotetan, by start year
Year	Studies
2002	1
2010	1
2014	1
2026	1

By phase

A phase 1/2 study counts in both.

Phase 1: 1
Phase 2: 2
Phase 3: 1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Cholecystitis: 1
Escherichia coli Infections: 1

Who runs them

Industry 1 · Other 3

Chonbuk National University Hospital (1) · Merck Sharp & Dohme LLC (1) · National Cancer Center, Korea (1) · Oregon Health and Science University (1)

Often tested with

Tested in the same studies.

L 749345 (1)

Studies

Open first, then newest update. How each study uses Cefotetan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 4

What changed recently

From the registry's own updates since Oct 15, 2026.

Started recruiting1

Cefotetan Therapy for Escherichia Coli InfectionsOct 16, 2026NCT07318584

Codes

What other systems call Cefotetan · ClinicalTrials.gg INT008462

MeSH (NLM) D015313CefotetanConfirmed ClinicalTrials.gov, NLM, Wikidata
UNII (FDA) 48SPP0PA9QCEFOTETANConfirmed FDA, NLM, Wikidata
RxNorm 2187Confirmed FDA, Wikidata
Wikidata Q2602246CefotetanConfirmed FDA, NLM, Wikidata
NCI Thesaurus C61664CefotetanOne source FDA
DrugBank DB01330One source Wikidata

System	Code	Name there	Checked by
MeSH (NLM)	D015313	Cefotetan	Confirmed ClinicalTrials.gov, NLM, Wikidata
UNII (FDA)	48SPP0PA9Q	CEFOTETAN	Confirmed FDA, NLM, Wikidata
RxNorm	2187	—	Confirmed FDA, Wikidata
Wikidata	Q2602246	Cefotetan	Confirmed FDA, NLM, Wikidata
NCI Thesaurus	C61664	Cefotetan	One source FDA
DrugBank	DB01330	—	One source Wikidata

Also registered as cefotetan disodium (UNII 0GXP746VXB · RxNorm 203141).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.